title: [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
authors.affiliation: Departamento de Pediatría, Hospital Universitario San Carlos, Madrid.
authors.forename: B
authors.initials: B
authors.lastname: Real Rodríguez
authors.forename: J L
authors.initials: JL
authors.lastname: Ruibal
authors.forename: S
authors.initials: S
authors.lastname: Grande Rodríguez
authors.forename: B
authors.initials: B
authors.lastname: Sueiro Pita
mesh_terms: D000293:Adolescent; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects; D001971:Bromocriptine / Q000627:therapeutic use*; D003620:Dantrolene / Q000627:therapeutic use*; D003975:Diazepam / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D007099:Imipramine / Q000009:adverse effects; D008140:Lorazepam / Q000009:adverse effects; D008297:Male; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors
chemical_list: D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D009125:Muscle Relaxants, Central; D001971:Bromocriptine; D003620:Dantrolene; D006220:Haloperidol; D008140:Lorazepam; D007099:Imipramine; D003975:Diazepam